Simplicity sacrificed in the FIGO 2023 endometrial cancer staging: Demystifying the complexity of twelve stages and seventeen substages

Authors

Keywords:

FIGO 2023 endometrial cancer staging

Abstract

Endometrial cancer incidence is rapidly rising globally, and in recent years, research has gained significant momentum. Surgical techniques, histopathology classification, risk stratification and understanding of different adjuvant modalities have progressed a great deal since the last endometrial cancer FIGO (The International Federation of Gynecology and Obstetrics) staging revision in 2009.1 Simultaneous rapid advances in the development of targeted therapies, accompanied by improved molecular and genetic diagnostics have contributed to a significant change in our understanding of the disease.

Author Biographies

  • G Dreyer, University of Pretoria

    Department of Obstetrics and Gynaecology and Gynaecological Oncology Unit, University of Pretoria, South Africa

  • LC Snyman, University of Pretoria

    Department of Obstetrics and Gynaecology and Gynaecological Oncology Unit, University of Pretoria, South Africa

Downloads

Published

2023-11-22

Issue

Vol. 15 No. 1 (2023)

Section

Opinion

License

South African Journal of Gynaecological Oncology (SAJGO) Copyright is held by South African Society of Gynaecologic Oncology (SASGO). Copyright of the articles is held by the authors. The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License (CC BY NC). Material submitted for publication in the SAJGO is accepted provided it has not been published elsewhere. The SAJGO does not hold itself responsible for statements made by the authors. The opinions expressed in this publication are those of the authors. They do no purport to reflect the opinions or views of SASGO or its members.